SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : UTHR-a Promising Biotech in the works here?
UTHR 445.43-1.8%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LzzrdKing who wrote (23)8/23/1999 11:37:00 PM
From: kendall harmon   of 66
 
UTHR-If anyone can by any chance track down the ag edwards report I would be grateful to hear from it or see it

Princeton, New Jersey, July 19 (Bloomberg Data) -- United Therapeutics Corp. (UTHR US) was rated ''buy'' in new coverage by analyst Kenneth R. Nover at A.G. Edwards & Sons Inc. The 12-month target price is $30.00 per share.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext